In subsequent studies, it was found that ILP-2 is highly expressed in various tumors such as nasopharyngeal carcinoma, breast cancer, liver cancer, hematological tumors, and neuroblastoma (12, 13). Here, BIRC8 is linked to breast carcinoma.